Inventor

CAMUSSI GIOVANNI

IT19 patents

⚠️ This page may combine multiple inventors who share the name “CAMUSSI GIOVANNI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CAMUSSI GIOVANNI

UNICYTE EV AG

Extracellular vesicles derived from human liver stem cells (HLSCs)

Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia

Composition of extracellular vesicles (EVS) and medical uses thereof

Isolation of extracellular vesicles (EVs) from biological fluid samples

Composition of extracellular vesicles (EVS) and medical uses thereof

Pharmaceutical carriers containing miRNAs for use in the treatment of renal cancer

Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia

FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH

Conditioned medium of liver progenitor cells

Pancreatic islet-like cell structures and a method of preparing thereof

Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease

Pancreatic islet-like cell structures and a method of preparing thereof

HERRERA SANCHEZ MARIA BEATRIZ

Liver progenitor cells

Conditioned medium of liver progenitor cells

Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease

CAMUSSI GIOVANNI

Human CD154-binding synthetic peptide and uses thereof

Isolated multipotent mesenchymal stem cell from human adult glomeruli (HGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney

CANTALUPPI VINCENZO

Use of microvesicles (MVs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods

BRUNO STEFANIA

Microvesicles (MVS) derived from adult stem cells for use in the therapeutic treatment of a tumor disease

FRESENIUS MEDICAL CARE DE GMBH

Use of microvesicles (MVs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related to in vitro or in vivo methods